Dr. Diego Antonio Rielo, MD

Dr. Rielo practices at Diego Rielo MD PA in Pembroke Pines, Florida.

Dr. Rielo's NPI, 1720058233, was assigned on January 25, 2006. Dr. Rielo graduated from Superior Institute of Medical Sciences of Santiago de Cuba in 1989. Dr. Rielo holds Florida license ME81040.

Dr. Rielo's primary practice is Diego Rielo MD PA, at 601 N Flamingo Rd, Pembroke Pines, FL 33028 in Broward County. The practice phone is (305) 560-5302.

Dr. Rielo's primary practice is Diego Rielo MD PA in Pembroke Pines, Florida. The medical group on file is Floridian Clinical Research. Dmand AI also links Dr. Rielo to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rielo practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rielo's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rielo is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Rielo's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists epilepsy among the conditions Dr. Rielo treats.

CMS data shows 23 Medicare services from Dr. Rielo across 1 procedure code in 2024, all of them office visits, for 21 Medicare patients. Medicare paid $2,452 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Dr. Rielo in 2024. 75% of them have high cholesterol, and 67% have diabetes. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rielo's median patient age at 74, with 62% women.

In 2024, Dr. Rielo wrote 589 Medicare Part D claims for 75 patients. 96% of them were for generic drugs. CMS names the drug for 506 of them, across 20 drugs with 11 or more claims each, at $29,381 in total drug cost. In 2023, CMS named 396 claims across 14 drugs.

Dr. Rielo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Rielo to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Alzheimer Disease.

CMS Open Payments shows 150 general payments to Dr. Rielo from 35 drug and device companies from 2016 to 2019. Gifts make up the largest share, 71% of the total. Allergan Inc. paid the most, $6,315. It also lists 2 research payments totaling $1,697 in 2023.

Dmand AI lists 1 award for Dr. Rielo, most recently CMS Stage 1 EHR in 2013.

Dr. Rielo graduated from Superior Institute of Medical Sciences of Santiago de Cuba in 1989.

Dr. Rielo is in network with 7 carriers, including Aetna, Humana and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.